Ledger.Open graph →
SEC Form D · Amendment · filed April 9, 2010

Nautilus Neurosciences, Inc

Offering
$17.8M
Sold
$17.8M
Exemption
—
Industry
Pharmaceuticals
Location
BRIDGEWATER, NJ
Type
—

People & firms on this filing (14)

William Maichle · Bridgewater, NJExecRobert Russell · Calgary, Alberta, CanadaDirectorEric J. Liebler · Bridgewater, NJExec · DirectorNeil R. Milano · Bridgewater, NJExecJames L. Fares · Bridgewater, NJExec · DirectorNavjot Athwal · San Franciso, CADirectorDouglas M. Karp · New York, NYDirectorSiobhan C. Foy · Walnut Creek, CADirectorMatthew Q. Giffuni · Fort Lauderdale, FLDirectorJohn P. Fitzsimons · New York, NYExec · DirectorLawrence A. First · New York, NYDirectorChristopher J. Risewick · Des Moines, IAExec · DirectorDennis Folden · West Des Moines, IAExecBenjamin T. Sporn · Newton Center, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗